Baidu
map

Sci Transl Med:基因修饰T细胞帮助免疫系统攻击肿瘤

2014-11-17 佚名 生物谷

基因修饰T细胞因可帮助人体免疫系统识别并攻击肿瘤,为此被称为肿瘤治疗的"第五支柱"。 上述治疗方法已经在血癌,如白血病中显示出治疗功效。在某些肿瘤类型如间皮瘤治疗过程中,当这些“修修补补”的T细胞被再注入到患者血液中时,患者肿瘤会很好抵抗T细胞攻击。 研究人员试图直接向肿瘤区域提供基因修饰后的T细胞,并发现这些T细胞不仅攻击了癌细胞,同时成功阻断了癌症再次发生。他们的研究结果发表在Scienc

基因修饰T细胞因可帮助人体免疫系统识别并攻击肿瘤,为此被称为肿瘤治疗的"第五支柱"。

上述治疗方法已经在血癌,如白血病中显示出治疗功效。在某些肿瘤类型如间皮瘤治疗过程中,当这些“修修补补”的T细胞被再注入到患者血液中时,患者肿瘤会很好抵抗T细胞攻击。

研究人员试图直接向肿瘤区域提供基因修饰后的T细胞,并发现这些T细胞不仅攻击了癌细胞,同时成功阻断了癌症再次发生。他们的研究结果发表在Science Translational Medicine杂志上。

该研究主要使用人源T细胞和小鼠肿瘤,其研究结果有助于加快开展1期临床试验。研究人员尝试了两种静脉注射,将重新装备(基因修饰)的T细胞注射入间皮瘤小鼠胸膜腔。奇怪的是,当基因修饰的T细胞到达肿瘤部位,它们能“看到”敌人(癌细胞),激活自己的同时也激活其他T细胞。

十多年来,研究人员已经尝试了基因改变T细胞使其产生受体,以匹配肿瘤细胞的抗原。上个月,研究人员在费城儿童医院报道,当患者的T细胞进行基因修饰并重新引入患者体内后,30名晚期复发的白血病患者中有27名患者经历缓解期。

原始出处

Adusumilli PS1, Cherkassky L2, Villena-Vargas J2, Colovos C2, Servais E2, Plotkin J3, Jones DR4, Sadelain M5.Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.Sci Transl Med. 2014 Nov

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2067154, encodeId=abf2206e15484, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Aug 16 06:11:00 CST 2015, time=2015-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656627, encodeId=9389165662e0c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat Feb 21 08:11:00 CST 2015, time=2015-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569260, encodeId=c1661569260a9, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599929, encodeId=46b71599929d3, content=<a href='/topic/show?id=7a7d4168e3a' target=_blank style='color:#2F92EE;'>#基因修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41687, encryptionId=7a7d4168e3a, topicName=基因修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069c18767911, createdName=apoenzyme, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606325, encodeId=72b31606325c5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2067154, encodeId=abf2206e15484, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Aug 16 06:11:00 CST 2015, time=2015-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656627, encodeId=9389165662e0c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat Feb 21 08:11:00 CST 2015, time=2015-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569260, encodeId=c1661569260a9, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599929, encodeId=46b71599929d3, content=<a href='/topic/show?id=7a7d4168e3a' target=_blank style='color:#2F92EE;'>#基因修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41687, encryptionId=7a7d4168e3a, topicName=基因修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069c18767911, createdName=apoenzyme, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606325, encodeId=72b31606325c5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=)]
    2015-02-21 bsmagic9140
  3. [GetPortalCommentsPageByObjectIdResponse(id=2067154, encodeId=abf2206e15484, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Aug 16 06:11:00 CST 2015, time=2015-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656627, encodeId=9389165662e0c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat Feb 21 08:11:00 CST 2015, time=2015-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569260, encodeId=c1661569260a9, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599929, encodeId=46b71599929d3, content=<a href='/topic/show?id=7a7d4168e3a' target=_blank style='color:#2F92EE;'>#基因修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41687, encryptionId=7a7d4168e3a, topicName=基因修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069c18767911, createdName=apoenzyme, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606325, encodeId=72b31606325c5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=)]
    2014-11-19 zhangyxzsh
  4. [GetPortalCommentsPageByObjectIdResponse(id=2067154, encodeId=abf2206e15484, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Aug 16 06:11:00 CST 2015, time=2015-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656627, encodeId=9389165662e0c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat Feb 21 08:11:00 CST 2015, time=2015-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569260, encodeId=c1661569260a9, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599929, encodeId=46b71599929d3, content=<a href='/topic/show?id=7a7d4168e3a' target=_blank style='color:#2F92EE;'>#基因修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41687, encryptionId=7a7d4168e3a, topicName=基因修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069c18767911, createdName=apoenzyme, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606325, encodeId=72b31606325c5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2067154, encodeId=abf2206e15484, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Aug 16 06:11:00 CST 2015, time=2015-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656627, encodeId=9389165662e0c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat Feb 21 08:11:00 CST 2015, time=2015-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569260, encodeId=c1661569260a9, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599929, encodeId=46b71599929d3, content=<a href='/topic/show?id=7a7d4168e3a' target=_blank style='color:#2F92EE;'>#基因修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41687, encryptionId=7a7d4168e3a, topicName=基因修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069c18767911, createdName=apoenzyme, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606325, encodeId=72b31606325c5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Nov 19 00:11:00 CST 2014, time=2014-11-19, status=1, ipAttribution=)]

相关资讯

ESMO 2014:转移性乳腺癌基因组学和免疫学有何特征?

在本次EMSO年会上公布的一项研究表明,转移性乳腺癌(mBC)与原发肿瘤在免疫和基因组学方面存在显著差异,并且可能涉及耐药机制或迁移过程的基因增多。肿瘤浸润淋巴细胞(TIL)、PD-1和PD-L1在转移性病灶中很少见(除外HER+mBC)。研究者称,该结果提示在mBC中可能存在其他免疫抑制通路。 此项研究从SAFIR01和MOSCATO试验中回顾性确认了对转移性病变实施分子筛查的患者。利用Hi-

两篇《细胞》文章:发布CRISPR研究重大突破

日前,来自加州大学旧金山分校的科学家在《细胞》(Cell)杂志上报告称,他们应用一种新型的、精确的方法开启和关闭了细胞内的基因。这一成果有可能促成更好地了解疾病以及开发出新的治疗方法。 这一研究进展的核心是一个叫做SunTag的新发明。SunTag实质上是一套分子挂钩,其能够将多个拷贝的生物活性分子挂到可用来靶向一些基因或其他的分子的蛋白质支架上。相比于没有这些挂钩的组装分子,整合了Su

英研究发现快乐与否跟基因有关

台媒称,欧洲人老爱说法国人天生乖戾,怎么瞧都不顺眼。最新科学研究指出,英、美两国人也好不到哪里去,原因在于基因比较短,天生就抑郁寡欢,即便政府稳定、经济良好,也不会像别国人那样快乐。 台湾中时电子报10月30日援引英国《每日邮报》的报道称,英国华威大学(University of Warwick)科学家发现,人是否天生快乐,与脑中有一型专门调节血清素(serotonin)荷尔蒙的基因有关。该基因

雅虎推出基因分析 可检查癌症发病几率

据日本Mapion网站11月10日报道,近日,雅虎日本旗下网站“雅虎HealthCare”组织开展了一项名为“HeathData Lab”的研究活动,现已开始向大众提供检查病情发生几率以及身体状况等信息的基因组分析服务,其价格为49800日元(约合人民币2665元)。 据悉,这项服务可以分析出肺癌、大肠癌、前列腺癌等22种癌症的发病几率,也可以分析出2型糖尿病、脑卒中、心肌梗塞、肥胖等病情

癌症或为细胞进入“安全模式”所产生

癌症是人体细胞试运转“安全模式”所产生的吗,就像受损计算机系统在面临外部威胁时试着保护自己那样?这是美国亚利桑那州立大学宇宙学家Paul Davies和同事得出的结论,他们提出了一个备受争议的癌症起源新理论。该理论主要基于癌症的进化根源。如果该理论正确,他们的模型提示,氧气治疗和感染病毒或细菌的一些非传统疗法可能尤其有效。 乍看之下,Davies似乎不像“癌症战争”中的战士,他是物理学出身,而非

NEJM:年龄和基因影响埃博拉患者存活率

什么因素影响着埃博拉患者的生与死?首当其冲的是年龄。一项在塞拉利昂的实地观察发现,与老年人相比,年轻人更容易战胜埃博拉病毒。但基因影响也不容忽视,一项小鼠实验显示,如果某些人促进血管修复和免疫力的基因比较活跃,那么他们的病情会相对较轻。 新一期美国《新英格兰医学杂志》发表了一些医护人员在塞拉利昂某医院的观察结果,他们共接诊了213名出现埃博拉症状的病人,其中有106人被确诊感染埃博拉病毒

Baidu
map
Baidu
map
Baidu
map